Simple Summary The most appropriate treatment for local/regional recurrent differentiated
thyroid cancers (DTC) is surgical excision if feasible, followed by adjuvant radioiodine …

Background We identified factors predictive of outcome for recurrent differentiated thyroid
carcinoma (DTC). Methods Fifty-seven patients with local (LR), regional (RRec), and/or …

Introduction: Management of recurrent differentiated thyroid cancer (DTC) may include
surgery, radioactive iodine (RAI), and external beam radiotherapy (EBRT). Systemic therapy …

Treatment of metastatic differentiated thyroid cancer is first based on the use of radioiodine
and thyrotropin-suppressive thyroid hormone treatment. The recent availability of molecular …

The term “relapse carcinoma” is used improperly to indicate either a local or loco-regional
relapse or a systematic metastatsis [1]. Local relapse (LR) after thyroidectomy for cancer is …

A 58-year-old man with metastatic radioiodine-refractory differentiated thyroid cancer (DTC)
presented with left thigh and right flank numbness. He had known progressive and …

Thyroid cancer is relatively rare, accounting for 0.5–10 cases per 100,000 individuals per
year. Despite their generally favourable prognosis, patients with differentiated thyroid cancer …

Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …

Simple Summary Surgery is generally the treatment of choice for locoregional recurrences of
well-differentiated thyroid carcinomas, but other therapies can be considered on an …

Recurrent thyroid cancer: a molecular-based therapeutic brea... : Current Opinion in
Oncology Recurrent thyroid cancer: a molecular-based therapeutic breakthrough : Current …